1. Home
  2. NYXH vs RDCM Comparison

NYXH vs RDCM Comparison

Compare NYXH & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • RDCM
  • Stock Information
  • Founded
  • NYXH 2009
  • RDCM 1985
  • Country
  • NYXH Belgium
  • RDCM Israel
  • Employees
  • NYXH N/A
  • RDCM N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • RDCM Computer peripheral equipment
  • Sector
  • NYXH Health Care
  • RDCM Technology
  • Exchange
  • NYXH Nasdaq
  • RDCM Nasdaq
  • Market Cap
  • NYXH 188.1M
  • RDCM 215.2M
  • IPO Year
  • NYXH 2021
  • RDCM 1997
  • Fundamental
  • Price
  • NYXH $4.60
  • RDCM $12.89
  • Analyst Decision
  • NYXH Strong Buy
  • RDCM Strong Buy
  • Analyst Count
  • NYXH 3
  • RDCM 1
  • Target Price
  • NYXH $12.67
  • RDCM $18.00
  • AVG Volume (30 Days)
  • NYXH 47.3K
  • RDCM 59.1K
  • Earning Date
  • NYXH 11-13-2025
  • RDCM 11-12-2025
  • Dividend Yield
  • NYXH N/A
  • RDCM N/A
  • EPS Growth
  • NYXH N/A
  • RDCM 37.57
  • EPS
  • NYXH N/A
  • RDCM 0.64
  • Revenue
  • NYXH $6,616,215.00
  • RDCM $68,901,000.00
  • Revenue This Year
  • NYXH $85.62
  • RDCM $18.07
  • Revenue Next Year
  • NYXH $320.09
  • RDCM $11.52
  • P/E Ratio
  • NYXH N/A
  • RDCM $20.14
  • Revenue Growth
  • NYXH 10.96
  • RDCM 17.27
  • 52 Week Low
  • NYXH $4.35
  • RDCM $9.88
  • 52 Week High
  • NYXH $11.87
  • RDCM $15.98
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 39.26
  • RDCM 47.10
  • Support Level
  • NYXH $4.45
  • RDCM $12.12
  • Resistance Level
  • NYXH $4.76
  • RDCM $13.10
  • Average True Range (ATR)
  • NYXH 0.30
  • RDCM 0.58
  • MACD
  • NYXH -0.04
  • RDCM 0.02
  • Stochastic Oscillator
  • NYXH 13.25
  • RDCM 33.00

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

Share on Social Networks: